Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
NCT 03959085 Brief Summary This phase III trial studies whether inotuzumab ozogamicin…
Read more arrow_forwardNCT 03959085 Brief Summary This phase III trial studies whether inotuzumab ozogamicin…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.